Chiang Mai University is a public research university in northern Thailand founded in 1964. It has a strong emphasis on engineering, science, agriculture, and medicine. Its instructional mission includes undergraduate, graduate, professional and continuing education offered through resident instruction.

During the past decade, Chiang Mai University conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 8 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chiang Mai University" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Chiang Mai University" with 5 trials sponsored, "AIDS Clinical Trials Group" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chiang Mai University" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "HIV Prevention Trials Network" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Chiang Mai University" are "HIV Infections" (5 trials), "Acquired Immunodeficiency Syndrome" (2 trials), "Carcinoma, Hepatocellular" (2 trials), "Depression" (2 trials) and "HIV" (2 trials). Many other conditions were trialed in "Chiang Mai University" in a lesser frequency.

Most popular intervention types in "Chiang Mai University" are "Drug" (28 trials), "Other" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "E/C/F/TAF" (3 trials), "ATV" (2 trials), "E/C/F/TDF" (2 trials) and "E/C/F/TDF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chiang Mai University" are 36 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Chiang Mai University". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Chiang Mai University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chiang Mai University, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Chiang Mai University has several departments that took part in Clinical trials: "Faculty of Medicine, Chiang Mai University" - 24 trials, "Department of Physical Therapy, Faculty of Associated Medical Sciences" - 5 trials, "Department of Anesthesiology, Faculty of Medicine, Chiang Mai University" - 4 trials, "Department of OB-GYN, Faculty of Medicine, Chiang Mai University" - 6 trials, "Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University" - 2 trials, "Department of Otolaryngology Faculty of Medicine, Chiang Mai University 110 Intawaroros Road, Sriphum" - 2 trials, "Department of Orthopedics, Chiang Mai University" - 2 trials